Subscribe to our Coronavirus podcast with analysis of the impact on health, business and travel in the UK and beyond: https://www.playpodca.st/coronavirus

As results of the first human trials of Oxford University vaccine show immune reaction produced without any serious adverse reactions, virologist Dr Elisabetta Groppelli joins Theodora Louloudis to discuss why she thinks the results are ‘very, very encouraging’, whether a vaccine is ‘one size fits all’ and how virus mutation could affect crucial immunology research.

Read more about the potential coronavirus treatment from Synairgen: https://www.telegraph.co.uk/news/2020/07/20/coronavirus-treatment-synairgen-hailed-game-changer-trial-results/

Read more about Test and Trace privacy allegations: https://www.telegraph.co.uk/news/2020/07/20/privacy-body-accuses-nhs-test-trace-system-breaching-data-protection/

Read more about French face masks: https://www.telegraph.co.uk/news/2020/07/20/france-enforces-new-face-mask-measures-battles-500-coronavirus/

For 30 days' free access to The Telegraph: www.telegraph.co.uk/audio
Email: coronaviruspodcast@telegraph.co.uk

For 30 days’ free access to The Telegraph: https://telegraph.co.uk/audio?WT.mc_id=tmg_youtube_offsite_televideo-youtubevideo&utm_source=tmgoff&utm_medium=tmg_youtube&utm_content=offsite_televideo&utm_campaign=tmg_youtube_offsite_televideo-youtubevideo

Telegraph.co.uk and YouTube.com/TelegraphTV are websites of The Telegraph, the UK's best-selling quality daily newspaper providing news and analysis on UK and world events, business, sport, lifestyle and culture.